US Edition
Cognito’s Spectris AD slows Alzheimer's disease progression in trial
Summary by Medical Device Network
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Cognito’s Spectris AD slows Alzheimer's disease progression in trial
Cognito has reported outcomes from a post hoc analysis of its OVERTURE trial, indicating that the Spectris AD can slow the progression of Alzheimer’s.The post Cognito’s Spectris AD slows Alzheimer’s disease progression in trial appeared first on Medical Device Network.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
